Perrigo (PRGO) Liabilities from Discontinued Operations (2020 - 2026)
Perrigo (PRGO) posted quarterly Liabilities from Discontinued Operations of 28900000.0 for Q1 2026, up 542.22% year-over-year from 4500000.0 in Q1 2025, and up 7.84% quarter-over-quarter from 26800000.0 in Q4 2025.
Perrigo (PRGO) Liabilities from Discontinued Operations (2020 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Liabilities from Discontinued Operations for 5 consecutive years, with 28900000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities from Discontinued Operations rose 542.22% year-over-year to 28900000.0; the TTM figure through Mar 2026 stood at 28900000.0 (up 542.22% YoY), while the FY2025 annual figure was 26800000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations rose to 28900000.0 in Q1 2026 per PRGO's latest filing, from 26800000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 51500000.0 in Q2 2024 and bottomed at 4500000.0 in Q1 2025.
- Historically, Liabilities from Discontinued Operations has averaged 26216666.67 across 3 years, with a median of 27850000.0 in 2025.
- Annual changes were most pronounced in 2025 — Liabilities from Discontinued Operations soared 356.1% — and 2026, when it soared 542.22%.
- Perrigo's Liabilities from Discontinued Operations stood at 8200000.0 in 2024, then surged by 226.83% to 26800000.0 in 2025, then climbed by 7.84% to 28900000.0 in 2026.
- Business Quant data shows PRGO's Liabilities from Discontinued Operations at 28900000.0 in Q1 2026, 26800000.0 in Q4 2025, and 37400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 28.90 Mn |
| Mar 28, 2026 | 28.90 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Sep 27, 2025 | 37.40 Mn |
| Sep 27, 2025 | 37.40 Mn |
| Mar 29, 2025 | 4.50 Mn |
| Mar 29, 2025 | 4.50 Mn |
| Sep 28, 2024 | 8.20 Mn |
| Sep 28, 2024 | 8.20 Mn |
| Jun 29, 2024 | 51.50 Mn |
| Jun 29, 2024 | 51.50 Mn |
| Dec 31, 2021 | 32.90 Mn |
| Dec 31, 2021 | 32.90 Mn |
| Oct 2, 2021 | 29.20 Mn |
| Oct 2, 2021 | 29.20 Mn |
| Jul 3, 2021 | 468.30 Mn |
| Jul 3, 2021 | 468.30 Mn |
| Apr 3, 2021 | 450.00 Mn |
| Apr 3, 2021 | 450.00 Mn |